Nutrition Research
Volume 26, Issue 12 , Pages 637-643, December 2006

Simvastatin and supplementation with ω-3 polyunsaturated fatty acids and vitamins improves claudication distance in a randomized PILOT study in patients with peripheral vascular disease

  • Juan J. Carrero

      Affiliations

    • Department of Biochemistry and Molecular Biology, University of Granada, Granada 18071, Spain
    • Corresponding Author InformationCorresponding author. K56. Divisions of Renal Medicine and Baxter Novum, Karolinska University Hospital at Huddinge, 14186 Stockholm, Sweden. Tel.: +46 8 58583982; fax: +46 8 58583925.
  • ,
  • Eduardo López-Huertas

      Affiliations

    • Department of Nutrition and Health, Puleva Biotech SA, Granada 18004, Spain
  • ,
  • Luis M. Salmerón

      Affiliations

    • Service of Angiology and Vascular Surgery, University “San Cecilio” Hospital, Granada 18012, Spain
  • ,
  • Victoria E. Ramos

      Affiliations

    • Service of Angiology and Vascular Surgery, University “San Cecilio” Hospital, Granada 18012, Spain
  • ,
  • Luis Baró

      Affiliations

    • Department of Nutrition and Health, Puleva Biotech SA, Granada 18004, Spain
  • ,
  • Eduardo Ros

      Affiliations

    • Service of Angiology and Vascular Surgery, University “San Cecilio” Hospital, Granada 18012, Spain

Received 19 June 2005; received in revised form 21 August 2006; accepted 26 September 2006.

Abstract 

Peripheral vascular disease (PVD) is a manifestation of systemic atherosclerosis. Statins and a number of nutrients are effective in controlling the risk for cardiovascular disease. We hypothesized that a combined intervention of a selection of nutrients together with simvastatin could ameliorate the risk factors and clinical symptoms in these patients. A 12-month longitudinal, randomized, controlled pilot study was conducted in which 40 male PVD patients with intermittent claudication were allocated into 4 intervention groups. Group S was provided with 500 mL/d of a fortified dairy product containing fish oil, oleic acid, folic acid, and other vitamins. Group SS consumed the same fortified product plus 20 mg/d of simvastatin. Group C was provided with 500 mL/d of semiskimmed milk, and group CS received semiskimmed milk plus simvastatin. Every 6 months, blood collections and clinical examinations were performed. Groups S and SS tripled their claudication distance (P < .001), and group SS increased ankle-brachial index (P < .05). Group S and SS increased their plasma levels of folate, eicosapentaenoic, docosahexaenoic, and oleic acids (P < .05) and decreased their homocysteine concentration (P < .05). In addition, group C had increased total and low-density lipoprotein cholesterol concentrations (P < .05). In the groups that consumed the nutritional supplement, the increase in claudication distance correlated with the increase of plasma docosahexaenoic acid (r = 0.40; P < .05). These results suggest that the combination of hypolipidemic therapy and a daily consumption of cardioprotective nutrients could be effective in PVD management. Moreover, this pilot study suggests that nutrients per se might play a major role in producing the benefits observed. Further studies are needed to clarify the potential role of nutritional interventions in PVD progression and management.

Keywords: Human, Peripheral vascular disease, Intermittent claudication, Simvastatin, Fish oil, Folic acid, B vitamins

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by a PhD educational grant from the University of Granada and by Puleva Biotech SA, Granada, Spain.

PII: S0271-5317(06)00240-5

doi:10.1016/j.nutres.2006.09.024

Nutrition Research
Volume 26, Issue 12 , Pages 637-643, December 2006